Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitis.

Saved in:
Bibliographic Details
Title: Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitis.
Authors: Taiwo M; Department of Inflammation and Immunity., Huang E; Department of Inflammation and Immunity., Pathak V; Department of Quantitative Health Sciences, and., Bellar A; Department of Inflammation and Immunity., Welch N; Department of Inflammation and Immunity.; Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA., Dasarathy J; Department of Family Medicine, Metro Health Medical Center, Cleveland, Ohio, USA., Streem D; Department of Psychiatry and Psychology, Cleveland Clinic Lutheran Hospital, Cleveland, Ohio, USA., McClain CJ; Department of Medicine, University of Louisville, Louisville, Kentucky, USA., Mitchell MC; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Barton BA; Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Szabo G; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Dasarathy S; Department of Inflammation and Immunity.; Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA.; Department of Molecular Medicine, Case Western Reserve University, Cleveland, Ohio, USA., Schaefer EA; Alcohol Liver Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA., Luther J; Alcohol Liver Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA., Day LZ; Biological Sciences Division and Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington, USA., Ouyang X; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Suyavaran A; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Mehal WZ; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; West Haven VA Medical Center, West Haven, Connecticut, USA, Jacobs JM; Biological Sciences Division and Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington, USA., Goodman RP; Alcohol Liver Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Endocrine Unit, Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA., Rotroff DM; Department of Quantitative Health Sciences, and.; Endocrine and Metabolism Institute; Center for Quantitative Metabolic Research, Cleveland Clinic, Cleveland, Ohio, USA., Nagy LE; Department of Inflammation and Immunity.; Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA.; See Supplemental Acknowledgments for information on the AlcHepNet Consortium
Corporate Authors: Alcohol Hepatitis Network (AlcHepNet) Consortium; See Supplemental Acknowledgments for information on the AlcHepNet Consortium
Source: JCI insight [JCI Insight] 2024 Apr 04; Vol. 9 (9). Date of Electronic Publication: 2024 Apr 04.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2379-3708
DOI:10.1172/jci.insight.174127